Evaluation of dosage adjustment in patients with renal impairment

被引:52
作者
Pillans, PI [1 ]
Landsberg, PG [1 ]
Fleming, AM [1 ]
Fanning, M [1 ]
Sturtevant, JM [1 ]
机构
[1] Princess Alexandra Hosp, Dept Clin Pharmacol, Brisbane, Qld 4102, Australia
关键词
adjustment; dosage; drug; renal impairment;
D O I
10.1046/j.1445-5994.2003.00330.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To determine whether appropriate dosage adjust-ments are made in patients with significant renal impairment for drugs with a high fractional renal clearance. Methods: Evaluation of dosage adjustment was performed in patients who were admitted to a 480-bed metropolitan hospital (Princess Alexandra Hospital, Brisbane, Australia) with an estimated creatinine clearance of less than or equal to40 mL/min. All drugs had a high fractional renal excretion. A prescribed dose within 30% of the calculated dose was considered appropriate. Results: Doses were found to be inappropriately high in 105 (42.2%) of 249 admission prescriptions of the targeted drugs. Doses were appropriately reduced in hospital in 32 patients (30.4%). Seventy-three (29.3%) prescriptions were continued with excessive doses. Only 34 prescriptions for the target drugs were initiated in hospital, of which 88.2% were appropriately dosed. Conclusions: A significant percentage of patients with renal impairment are admitted to hospital on inappro-priately high doses of drugs, with a high fractional renal excretion and low therapeutic index. Doses are appropriately reduced in hospital in some patients but there is still room for improvement.
引用
收藏
页码:10 / 13
页数:4
相关论文
共 16 条
[1]   ALLOPURINOL HYPERSENSITIVITY SYNDROME - A REVIEW [J].
ARELLANO, F ;
SACRISTAN, JA .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (03) :337-343
[2]   Sotalol proarrhythmia: A report of five cases and an audit of the use of sotalol in a teaching hospital [J].
Basta, MN ;
Leitch, JW ;
Fletcher, PJ .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1996, 26 (02) :167-170
[3]  
Bennett WM, 1997, AVERYS DRUG TREATMEN, P1725
[4]  
BRATER DC, 1993, DRUG USE RENAL DIS
[5]  
COCKCROFT DW, 1976, NEPHRON, V16, P13
[6]  
EMMERSON BT, 1987, BRIT J RHEUMATOL, V26, P445
[7]  
GAMBERTOGIA JG, 1993, DIS KIDNEY, P3235
[8]   SEVERE ALLOPURINOL TOXICITY - DESCRIPTION AND GUIDELINES FOR PREVENTION IN PATIENTS WITH RENAL-INSUFFICIENCY [J].
HANDE, KR ;
NOONE, RM ;
STONE, WJ .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (01) :47-56
[9]   Drug administration in patients with renal insufficiency - Minimising renal and extrarenal toxicity [J].
Matzke, GR ;
Frye, RF .
DRUG SAFETY, 1997, 16 (03) :205-231
[10]  
MCCLINTOCK AD, 1995, NEW ZEAL MED J, V108, P346